STAT Brand Studio

Genentech, *the* original biotech company, is celebrating its 50th anniversary in 2026. VP, US External Affairs Joy Russell stopped by the STAT Brand Studio multimedia lounge at #statsummit to talk with Britt Whitmore about the company's past, present, future, and its patient impact.

STAT 10 Year Anniversary When we named ourselves “STAT’’ 10 years ago, we conceded, “It takes a bit of chutzpah to name a digital-age life-sciences publication after a buzzword

STAT is 10!

Join us in reflecting on a decade of reporting from the frontiers of health and medicine.

We’re proud that since 2015 we’ve delivered urgent, authoritative, and impactful journalism.

Celebrate with us: www.statnews.com/stat-10th-an...
#STAT10 🧵

On its 10th anniversary, health care site STAT is flourishing - Poynter STAT proves a sharp concept and patient money can beat the odds in a brutal news economy

www.poynter.org/business-wor...

As global biotech competition intensifies and new R&D centers emerge, Boston faces a pivotal moment. Can it continue to lead the world in life sciences?

Join us for an in-person event in Cambridge, MA next month to find out!

www.statnews.com/event/local-...

At #STATBreakthrough Summit West, SBS spoke with Boston Scientific’s CMO about 3 AI use cases in cardiology — from scaling ECG data to spotting heart failure early.

We also discussed the intersection of evidence-based medicine and AI:

www.statnews.com/sponsor/2025...

@statnews.com #cardiology

STAT@ASCO 2025 ASCO 2025: The Latest in Cancer Research The ASCO annual meeting is widely considered one of the largest and most prestigious cancer research conferences

STAT is going to #ASCO25!

STAT reporters will be on the ground, delivering breaking oncology news and insights to help you stay ahead.

Here’s how to follow our coverage and connect with us during ASCO.

Explore all our offerings here: www.statnews.com/asco-2025/

SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases

www.statnews.com/event/rare-a...

SBS Event: Rethinking Innovation for Patients with Rare and Complex Chronic Diseases

www.statnews.com/event/rare-a...

Virtual Event | Rethinking Innovation for Patients with Rare and Complex Chronic Diseases Join STAT and Takeda on March 25 to explore how plasma-derived therapies are reshaping health care. Register now for this virtual event.

Expanding the scope of innovation is key to unlocking progress in health care. This STAT Brand Studio event will examine how a holistic approach to innovation is reshaping the development and delivery of solutions to benefit patients.

Join us live tomorrow!

A new, iterative model of drug discovery using AI After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade

Biotherapeutic discovery has a low success rate, but Genentech aims to speed up and scale this process by using AI to transform the traditional, sequential drug discovery model into a cyclical and iterative one.

City of Hope’s president on accelerated growth, clinical trials, and emerging microbiome research One of the largest and most advanced cancer research and treatment organizations in the U.S., City of Hope is a global leader in innovative research and

https://www.statnews.com/sponsor/2024/12/23/city-of-hopes-president-on-accelerated-growth-clinical-trials-and-emerging-microbiome-research/

Over the past two years, City of Hope has significantly expanded, transforming cancer care and improving patient access. At the STAT Summit, Marcel van den Brink, M.D., Ph.D., highlighted their clinical trial network, novel therapies, and research on the microbiome's role in immune response.

Fighting colorectal cancer disparities with real-world data STAT Brand Studio · Episode

Colorectal cancer remains the 2nd leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how data and collaboration is driving efforts to close these gaps.

www.statnews.com/sponsor/2024...

“I think this personalized pathway is what we’re really driving towards…”

Hear more from Dr. Joan Cangiarella, Elaine Langone Professor of Pathology at the NYU Grossman School of Medicine and Senior Associate Dean for Education, Faculty, and Academic Affairs at @nyulangone.

Three-year degree expands access to medical education and fast-tracks specialty study NYU Grossman School of Medicine is transforming medical education with an innovative three-year medical degree and tuition-free enrollment. Senior

www.statnews.com/sponsor/2024...

Dr. Joan Cangiarella is the Sr. Associate Dean for Education, Faculty, and Academic Affairs at NYU Langone Health, one of the nation’s premier academic medical centers and health systems. She describes how NYU Langone is transforming medical education in a @statbrandstudio.bsky.social podcast: